PT - JOURNAL ARTICLE AU - Vineet Jain AU - Nusrat Nabi AU - Kailash Chandra AU - Sana Irshad AU - Varun kashyap AU - Sunil Kohli AU - Arun Gupta TI - A comparative analysis of COVID-19 mortality rate across the globe: An extensive analysis of the associated factors AID - 10.1101/2020.12.22.20248696 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.22.20248696 4099 - http://medrxiv.org/content/early/2020/12/22/2020.12.22.20248696.short 4100 - http://medrxiv.org/content/early/2020/12/22/2020.12.22.20248696.full AB - Background The vast variation in COVID 19 mortality across the globe draws attention to potential risk factors other than the patient characteristics that determine COVID-19 mortality.Subjects and Methods We have quantified and analyzed one of the broadest set of clinical factors associated with COVID-19-related death, ranging from disease related co-morbities, socioeconomic factors, healthcare capacity and government policy and interventions. Data for population, total cases, total COVID mortality, tests done, and GDP per capita were extracted from the worldometers database. Datasets for health expenditure by government, hospital beds, rural population, prevalence of smoking, prevalence of overweight population, deaths due to communicable disease and incidence of malaria were extracted from the World Bank website. Prevalence of diabetes was retrieved from the indexmundi rankings. The average population age, 60+ population, delay in lockdown, population density and BCG data were also included for analysis. The COVID-19 mortality per million and its associated factors were retrieved for 56 countries across the globe. Quantitative analysis was done at the global as well as continent level. All the countries included in the study were categorized continent and region wise for comparative analysis determining the correlation between COVID 19 mortality and the aforementioned factors.Results There was significant association found between mortality per million and 60+ population of country, average age, prevalence of diabetes mellitus, and case fatality rate with correlation and p value (p) of 0.422 (p 0.009), 0.386 (p 0.0186), −0.384 (p 0.019) and 0.753 (p 0.000) respectively at 95% CI.Conclusion The study observations will serve as a evidence based management strategy for generating predictive model for COVID-19 infection and mortality rate.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNilAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNil